跳至主要内容
临床试验/NCT01293786
NCT01293786已完成不适用

Comparison of Vascular Calcification Between Kidney Transplant Recipients and Predialysis Chronic Kidney Disease and Its Association With Serum Magnesium

Ramathibodi Hospital1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
400
试验地点
1
主要终点
The difference in vascular calcification score between KT and CKD

研究概览

简要总结

Both Kidney transplantation (KT) and Chronic Kidney Disease (CKD) patients have reduced kidney function. Low serum magnesium is more prevalent in KT recipients. The present study examines the difference in vascular calcification between KT and CKD and its association with serum magnesium.

详细描述

Kidney transplantation (KT) improved quality of life and longevity of CKD patients. Nevertheless, kidney function deteriorates overtime in a manner not different from CKD counterparts. Hypomagnesemia is prevalent in KT recipients secondary to immunosuppressive therapy. In addition to serum calcium, phosphate and elemental calcium intake, the relationship between low serum magnesium and vascular calcification (VC) has been observed in small studies in CKD. Whether low serum magnesium associates with VC in KT has never been elucidated. The present study compares vascular calcification between KT and CKD and its association with serum magnesium.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • kidney transplant recipients at least 1 year post surgery
  • predialysis chronic kidney disease with serum creatinine > 1.1 mg/dL in female and 1.3 mg/dL in male

排除标准

  • acute kidney injury
  • parathyroidectomy

结局指标

主要结局

The difference in vascular calcification score between KT and CKD

时间窗: Baseline

次要结局

  • The association of serum magnesium with vascular calcification in CKD(Baseline)
  • The association of serum magnesium with vascular calcification in KT(Baseline)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验